1. The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans;Blech;Drug Metab. Dispos.,2008
2. Effect of rifampin on the pharmacokinetics of apixaban, an oral direct inhibitor of factor Xa;Vakkalagadda;Am. J. Cardiovasc. Drugs,2016
3. Bioavailability and safety of the factor Xa inhibitor edoxaban and the effects of quinidine in healthy subjects;Matsushima;Clin. Pharmacol Drug Dev.,2013
4. The effect of food on the absorption and pharmacokinetics of rivaroxaban;Stampfuss;Int. J. Clin. Pharmacol. Ther.,2013
5. Pharmacokinetics, biotransformation, and mass balance of edoxaban, a selective, direct factor Xa inhibitor, in humans;Bathala;Drug Metab. Dispos.,2012